• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    Transition Therapeutics Inc. (TTHI)

    -NasdaqGM
    0.92 0.00(0.00%) Feb 12, 3:59PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Jun 30, 2014Jun 30, 2013
    Total Revenue -   -   16,999  
    Cost of Revenue -   -   -  
    Gross Profit -   -   16,999  
    Operating Expenses
    Research Development39,417  16,305  8,401  
    Selling General and Administrative4,470  4,611  3,372  
    Non Recurring -   -  6,205  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (43,886) (20,916) (979)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,764  466  1,001  
    Earnings Before Interest And Taxes(41,123)(20,450)22  
    Interest Expense -   -   -  
    Income Before Tax(41,123)(20,450)22  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(41,123)(20,450)22  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (41,123) (20,450) 22  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (41,123) (20,450) 22  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.